These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 14696848)

  • 1. Serum thyroglobulin as a marker of thyroid neoplasms after childhood cancer.
    Lando A; Holm K; Nysom K; Krogh Rasmussen A; Høier Madsen M; Feldt-Rasmussen U; Müller J
    Acta Paediatr; 2003 Nov; 92(11):1284-90. PubMed ID: 14696848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The diagnostic use of the rhTSH/thyroglobulin test in differentiated thyroid cancer patients with persistent disease and low thyroglobulin levels.
    Pellegriti G; Scollo C; Regalbuto C; Attard M; Marozzi P; Vermiglio F; Violi MA; Cianci M; Vigneri R; Pezzino V; Squatrito S
    Clin Endocrinol (Oxf); 2003 May; 58(5):556-61. PubMed ID: 12699436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid neoplasms after therapeutic radiation for malignancies during childhood or adolescence.
    Acharya S; Sarafoglou K; LaQuaglia M; Lindsley S; Gerald W; Wollner N; Tan C; Sklar C
    Cancer; 2003 May; 97(10):2397-403. PubMed ID: 12733137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Advances in thyroglobulin assays and their impact on the management of differentiated thyroid cancers].
    d'Herbomez M; Lion G; Béron A; Wémeau JL; DoCao C
    Ann Biol Clin (Paris); 2016; 74(1):21-7. PubMed ID: 26711165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On-levothyroxine measurement of thyroglobulin is not a reliable test for the follow-up of patients at high risk for remnant/recurrent differentiated thyroid carcinoma.
    Gholamrezanezhad A; Saghari M; Mirpour S; Beiki D; Tarbiat A; Javan S; Abdollahzadeh J
    Endokrynol Pol; 2007; 58(2):100-4. PubMed ID: 17578824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evaluation of the value of first thyroglobulin determination in the diagnostics of metastases immediately following differentiated thyroid carcinoma surgery.
    Makarewicz J; Adamczewski Z; Rutkowski A; Mikosiński S; Knapska-Kucharska M; Gonerska-Szadkowska A; Oszukowska L; Karwowska A; Lewiński A
    Endokrynol Pol; 2006; 57(4):370-3. PubMed ID: 17006838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-operative stimulated thyroglobulin and neck ultrasound as personalized criteria for risk stratification and radioactive iodine selection in low- and intermediate-risk papillary thyroid cancer.
    Orlov S; Salari F; Kashat L; Freeman JL; Vescan A; Witterick IJ; Walfish PG
    Endocrine; 2015 Sep; 50(1):130-7. PubMed ID: 25792004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroglobulin in patients with differentiated thyroid carcinoma.
    Lindegaard MW; Paus E
    Scand J Clin Lab Invest Suppl; 1991; 206():79-84. PubMed ID: 1947763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative serum thyroglobulin and changes in serum thyroglobulin during TSH suppression independently predict follicular thyroid carcinoma in thyroid nodules with a cytological diagnosis of follicular lesion.
    Kim HJ; Mok JO; Kim CH; Kim YJ; Kim SJ; Park HK; Byun DW; Suh K; Yoo MH
    Endocr Res; 2017 May; 42(2):154-162. PubMed ID: 27936964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Undetectable sensitive serum thyroglobulin (<0.1 ng/ml) in 163 patients with follicular cell-derived thyroid cancer: results of rhTSH stimulation and neck ultrasonography and long-term biochemical and clinical follow-up.
    Chindris AM; Diehl NN; Crook JE; Fatourechi V; Smallridge RC
    J Clin Endocrinol Metab; 2012 Aug; 97(8):2714-23. PubMed ID: 22639286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Papillary Thyroid Carcinoma Recurrence: Low Yield of Neck Ultrasound With an Undetectable Serum Thyroglobulin Level.
    Epstein S; McEachern R; Khot R; Padia S; Patrie JT; Itri JN
    J Ultrasound Med; 2018 Oct; 37(10):2325-2331. PubMed ID: 29498418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neck Sonography and Suppressed Thyroglobulin Have High Sensitivity for Identifying Recurrent/Persistent Disease in Patients With Low-risk Thyroid Cancer Treated With Total Thyroidectomy and Radioactive Iodine Ablation, Making Stimulated Thyroglobulin Unnecessary.
    Domínguez JM; Nilo F; Contreras T; Carmona R; Droppelmann N; González H; Iturrieta V; Tuttle RM
    J Ultrasound Med; 2017 Nov; 36(11):2299-2307. PubMed ID: 28543974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of therapeutic doses of 131I in thyroid papillary carcinoma patients with elevated thyroglobulin level and negative 131I whole-body scan: comparative study.
    Koh JM; Kim ES; Ryu JS; Hong SJ; Kim WB; Shong YK
    Clin Endocrinol (Oxf); 2003 Apr; 58(4):421-7. PubMed ID: 12641624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroglobulin messenger ribonucleic acid levels in the peripheral blood of children with benign and malignant thyroid disease.
    Fenton C; Anderson JS; Patel AD; Lukes Y; Solomon B; Tuttle RM; Ringel MD; Francis GL
    Pediatr Res; 2001 Mar; 49(3):429-34. PubMed ID: 11228272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of residual and recurrent differentiated thyroid carcinoma by serum thyroglobulin measurement.
    Spencer CA; LoPresti JS; Fatemi S; Nicoloff JT
    Thyroid; 1999 May; 9(5):435-41. PubMed ID: 10365673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of diagnostic whole-body scanning and serum thyroglobulin in the presence of elevated serum thyrotropin during follow-up of anti-thyroglobulin antibody-positive patients with differentiated thyroid carcinoma who appeared to be free of disease after total thyroidectomy and radioactive iodine ablation.
    Rosario PW; Mineiro Filho AF; Lacerda RX; dos Santos DA; Calsolari MR
    Thyroid; 2012 Feb; 22(2):113-6. PubMed ID: 22224815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serial serum thyroglobulin measurements in the management of differentiated thyroid carcinoma.
    Black EG; Sheppard MC; Hoffenberg R
    Clin Endocrinol (Oxf); 1987 Jul; 27(1):115-20. PubMed ID: 3652482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic modalities in patients affected by differentiated thyroid carcinoma with high thyroglobulin levels and total body Iodium-131 negative: PET/CT use after recTSH].
    Biscontini G; Possa M; Sara R; Milella M; Rossetti C
    Minerva Endocrinol; 2004 Dec; 29(4):151-60. PubMed ID: 15765025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Thyroglobulin Doubling Time in Progressive Thyroid Cancer.
    Rössing RM; Jentzen W; Nagarajah J; Bockisch A; Görges R
    Thyroid; 2016 Dec; 26(12):1712-1718. PubMed ID: 27750024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Impact of Detectable Antithyroglobulin Antibodies Below the Reference Limit (Borderline) in Patients with Papillary Thyroid Carcinoma with Undetectable Serum Thyroglobulin and Normal Neck Ultrasonography After Ablation: A Prospective Study.
    Côrtes MCS; Rosario PW; Oliveira LFF; Calsolari MR
    Thyroid; 2018 Feb; 28(2):229-235. PubMed ID: 29325506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.